10mg/ml 30ml bottle
LGD-4033 is a selective androgen receptor modulator a novel non-steroidal, oral SARM that binds to AR with high affinity (Ki of ~1 nM) and selectivity, class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033 is expected to produce the therapeutic benefits of testosterone with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an oral route of administration. It demonstrates anabolic activity in muscles, anti-resorptive and anabolic activity in bones and a robust selectivity for muscle and bone versus prostate and sebaceous glands. LGD-4033 has recently completed a Phase I Multiple Ascending Dose study in healthy volunteers this randomized, double-blind, placebo-controlled Phase I study established the safety and tolerability of doses up to 22mg.
WARNING: This product, LGD-4033 is for research use only. LGD-4033 is NOT for human use and can be harmful if ingested into the body. LGD-4033 is for research laboratory use only and all LGD-4033 dosage amounts for non-human use and only research use must be consulted with by a trained professional. This product is NOT in a sterile solution and is NOT to be injected. LGD-4033 should only be handled by licensed, qualified professionals. LGD-4033 is not a drug, food, or cosmetic and should not be misbranded, misused or mislabeled as a drug, food or cosmetic. LGD-4033 is a research chemical for research purposes.